Expression and significance of notch signaling pathway in salivary adenoid cystic carcinoma

Annals of Diagnostic Pathology

Volumn 18, Issue 1, 2014, Pages 10-13

  Bell, Diana ^a   Hanna, Ehab Y ^a   Miele, Lucio ^b   Roberts, Dianna ^a   Weber, Randal S ^a   El Naggar, Adel K ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Adenoid cystic; Cancer stem cells; Carcinoma; Notch; Notch 2 Jagged 1; Targeted therapy

Indexed keywords

JAGGED1; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH4 RECEPTOR;

ADENOID CYSTIC CARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVA; SALIVARY GLAND; SIGNAL TRANSDUCTION; SURVIVAL RATE;

ADCC; ADENOID CYSTIC; ADENOID CYSTIC CARCINOMA; CANCER STEM CELLS; CARCINOMA; CSC; NOTCH; NOTCH-2/JAGGED-1; TARGETED THERAPY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCIUM-BINDING PROTEINS; CARCINOMA, ADENOID CYSTIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RECEPTORS, NOTCH; SALIVARY GLAND NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84890126109     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2013.10.001     Document Type: Article

References (23)

1. I. Leivo Insights into a complex group of neoplastic disease: advances in histopathologic classification and molecular pathology of salivary gland cancer Acta Oncol 45 6 2006 662 668
2. P.M. Speight, and A.W. Barrett Salivary gland tumours Oral Dis 8 5 2002 229 240
3. W.F. van Heerden, and E.J. Raubenheimer Intraoral salivary gland neoplasms: a retrospective study of seventy cases in an African population Oral Surg Oral Med Oral Pathol 71 5 1991 579 582
4. S.H. Barsky, and N.J. Karlin Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression J Mammary Gland Biol Neoplasia 10 3 2005 249 260
5. T. Reya, S.J. Morrison, M.F. Clarke, and I.L. Weissman Stem cells, cancer, and cancer stem cells Nature 414 6859 2001 105 111
6. M.S. Wicha, S. Liu, and G. Dontu Cancer stem cells: an old idea - a paradigm shift Cancer Res 66 4 2006 1883 1890 [discussion 95-6]
7. C.M. Fillmore, and C. Kuperwasser Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy Breast Cancer Res 10 2 2008 R25
8. J. Devaney, C. Stirzaker, and W. Qu Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers Cancer Epidemiol Biomarkers Prev 20 1 2011 148 159
9. G. Dontu, M. Al-Hajj, W.M. Abdallah, M.F. Clarke, and M.S. Wicha Stem cells in normal breast development and breast cancer Cell Prolif 36 Suppl 1 2003 59 72
10. G. Dontu, D. El-Ashry, and M.S. Wicha Breast cancer, stem/progenitor cells and the estrogen receptor Trends Endocrinol Metab 15 5 2004 193 197
11. E. Charafe-Jauffret, C. Ginestier, and F. Monville Stem cells and epithelial cancers: the example of breast cancer Ann Pathol 28 Spec No 1 1 2008 S30 S32
12. E. Charafe-Jauffret, F. Monville, C. Ginestier, G. Dontu, D. Birnbaum, and M.S. Wicha Cancer stem cells in breast: current opinion and future challenges Pathobiology 75 2 2008 75 84
13. L.C. Ding, L. She, and D.L. Zheng Notch-4 contributes to the metastasis of salivary adenoid cystic carcinoma Oncol Rep 24 2 2010 363 368
14. S. Sun, and Z. Wang ALDH high adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis Biochem Biophys Res Commun 396 4 2010 843 848
15. J.H. Zhou, E.Y. Hanna, D. Roberts, R.S. Weber, and D. Bell ALDH1 immunohistochemical expression and its significance in salivary adenoid cystic carcinoma Head Neck 35 4 2013 575 578
16. R.L. Dodd, and N.J. Slevin Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies Oral Oncol 42 2006 759 769
17. J. Gilbert, Y. Li, and H.A. Pinto Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group Head Neck 28 2006 197 204
18. S.A. Laurie, and L. Licitra Systemic therapy in the palliative management of advanced salivary gland cancers J Clin Oncol 24 2006 2673 2678
19. H. Kokemueller, G. Swennen, N. Brueggemann, P. Brachvogel, A. Eckardt, and J.E. Hausamen Epithelial malignancies of the salivary glands: clinical experience of a single institution-a review Int J Oral Maxillofac Surg 33 2004 423 432
20. H. Kokemuller, N. Bruggemann, P. Brachvogel, and A. Eckardt Malignant epithelial salivary gland tumors. Clinical review of 2 decades Mund Kiefer Gesichtschir 8 2004 191 201
21. A.J. Khan, M.P. DiGiovanna, and D.A. Ross Adenoid cystic carcinoma: a retrospective clinical review Int J Cancer 96 3 2001 149 158
22. M. Krams, R. Parwaresch, B. Sipos, K. Heidorn, D. Harms, and P. Rudolph Expression of the c-kit receptor characterizes a subset of neuroblastomas with favorable prognosis Oncogene 23 2 2004 588 595
23. R. Perez-Soler Phase II, clinical trial data with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib (OSI-774) in non-small-cell lung cancer Clin Lung Cancer 6 Suppl 1 2004 S20 S23